Aktienanalyse zu Senestech Inc (SNES)SNESSenestech Inc

SenesTech, Inc. develops and commercializes products for managing animal pest populations, initially rat populations, through fertility control. The Company’s product lines of fertility control products are: ContraPest, Evolve Rat, and Evolve Mouse. Its product, ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest targets the reproductive systems of both male and female Norway and roof rats beginning with the first breeding cycle following consumption, which can lead to sustained reductions in the rat population. The Evolve Rat is a soft bait product that contains the active ingredient, cottonseed oil, which reduces fertility in both male and female rats. The Evolve Mouse, a modified version of soft bait technology containing the active ingredient cottonseed oil, which limits reproduction of male and female mice after one to two breeding cycles following consumption. It operates in the Basic Materials sector (AGRICULTURAL CHEMICALS industry).

Senestech Inc shows potential for future growth, but current indicators suggest it may not be a good buy right now. The stock has a current price of $0.65, with a 1-year change of -83.99%, indicating significant decline. The RSI is at 38.654, suggesting it is nearing oversold territory, but the forward P/E ratio of 3.399 indicates potential undervaluation. However, the risk remains high due to a net income loss of $2.06 million in Q1 2026 and a YTD change of -70.73%.

2 analysts cover SNES: 2 rate it Buy, 0 Hold and 0 Sell. The average price target is 10.00.